Pharmicell (005690) — Cash Flow Reinvestment Rate
Pharmicell (005690) has a Cash Flow Reinvestment Rate of 2.17x as of September 2025, reinvesting ₩19.07 Billion (capex ₩622.48 Million plus investments ₩-18.44 Billion) from operating cash flow of ₩8.78 Billion. Check Pharmicell (005690) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharmicell Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Pharmicell across 6 annual periods. Explore Pharmicell (005690) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Pharmicell (2016–2024)
Year-by-year capital reinvestment analysis for Pharmicell. For live market cap and broader valuation context, see how much is Pharmicell worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.18x | ₩11.14 Billion | ₩3.50 Billion | ₩4.34 Billion | ▲ +215.1% |
| 2023 | 1.01x | ₩11.94 Billion | ₩11.81 Billion | ₩6.02 Billion | ▼ -79.7% |
| 2022 | 4.99x | ₩39.49 Billion | ₩7.91 Billion | ₩18.96 Billion | ▲ +930.4% |
| 2020 | 0.48x | ₩4.35 Billion | ₩8.98 Billion | ₩742.73 Million | ▼ -85.5% |
| 2018 | 3.34x | ₩11.39 Billion | ₩3.40 Billion | ₩4.68 Billion | ▼ -59.7% |
| 2016 | 8.30x | ₩8.21 Billion | ₩988.97 Million | ₩3.85 Billion | — |